Cargando…

Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II

The severe pediatric disorder mucolipidosis II (ML-II; also known as I-cell disease) is caused by defects in mannose 6-phosphate (Man-6-P) biosynthesis. Patients with ML-II exhibit multiple developmental defects, including skeletal, craniofacial and joint abnormalities. To date, the molecular mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrey, Aaron C., Flanagan-Steet, Heather, Johnson, Steven, Fan, Xiang, De la Rosa, Mitche, Haskins, Mark E., Nairn, Alison V., Moremen, Kelley W., Steet, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291639/ https://www.ncbi.nlm.nih.gov/pubmed/22046029 http://dx.doi.org/10.1242/dmm.008219

Ejemplares similares

Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
por: Barnes, Jarrod W., et al.
Publicado: (2020)

Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation
por: Lu, Po-Nien, et al.
Publicado: (2020)

TGF-β Regulates Cathepsin Activation during Normal and Pathogenic Development
por: Flanagan-Steet, Heather, et al.
Publicado: (2018)

A Biochemical Platform to Define the Relative Specific Activity of IDUA Variants Identified by Newborn Screening
por: Yu, Seok-Ho, et al.
Publicado: (2020)

A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency
por: Cline, Abigail, et al.
Publicado: (2012)

Protease-dependent defects in N-cadherin processing drive PMM2-CDG pathogenesis
por: Klaver, Elsenoor J., et al.
Publicado: (2021)

The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases
por: Naumchik, Brianna M., et al.
Publicado: (2020)

Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing
por: Klaver, Elsenoor, et al.
Publicado: (2019)

Severe multisystem pathology, metabolic acidosis, mitochondrial dysfunction, and early death associated with an X-linked AIFM1 variant
por: Moss, Tonya, et al.
Publicado: (2021)

Autophagic dysfunction in mucolipidosis type IV patients
por: Vergarajauregui, Silvia, et al.
Publicado: (2008)

Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
por: Idol, Rachel A., et al.
Publicado: (2014)

Lysosomal Cholesterol Accumulation Contributes to the Movement Phenotypes Associated with NUS1 Haploinsufficiency
por: Yu, Seok-Ho, et al.
Publicado: (2021)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022)

A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation
por: Chu, Jaime, et al.
Publicado: (2013)

Probing pathomechanisms of mucolipidosis II in fish
Publicado: (2012)

Hip Morphology in Mucolipidosis Type II
por: Ammer, Luise Sophie, et al.
Publicado: (2020)

The Dictyostelium Model for Mucolipidosis Type IV
por: Allan, Claire Y., et al.
Publicado: (2022)

Modulation of the NOTCH1 Pathway by LUNATIC FRINGE Is Dominant over That of MANIC or RADICAL FRINGE
por: Pennarubia, Florian, et al.
Publicado: (2021)

Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma
por: Westermann, Lena Marie, et al.
Publicado: (2020)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

Mucolipidosis type III, a series of adult patients
por: Oussoren, Esmee, et al.
Publicado: (2018)

Unique molecular signature in mucolipidosis type IV microglia
por: Cougnoux, Antony, et al.
Publicado: (2019)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV
por: Mepyans, Molly, et al.
Publicado: (2020)

The first genetically confirmed Japanese patient with mucolipidosis type IV
por: Saijo, Harumi, et al.
Publicado: (2016)

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV
por: Misko, Albert L., et al.
Publicado: (2022)

Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies
por: Park, Hyejung, et al.
Publicado: (2010)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011)

Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2019)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

Biochemical characteristics of a Korean patient with mucolipidosis III (pseudo-Hurler polydystrophy).
por: Song, Junghan, et al.
Publicado: (2003)

Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1
por: Spooner, Ellen, et al.
Publicado: (2013)

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2015)

Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report
por: Alegra, Taciane, et al.
Publicado: (2014)

Characterization of mesenchymal stem cells in mucolipidosis type II (I-cell disease)
por: KÖSE, Sevil, et al.
Publicado: (2019)

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
por: Ammer, Luise Sophie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5s38gp6lfghq65htbbc4p5d8o